Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Rivaroxaban 20 mg Immediate Release vs Xarelto in Healthy Thai Volunteers (Fed)
TCTR20210526003Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rivaroxaban, sponsored by Bio-innova. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
rivaroxaban
Beyond the preview
Go deeper on TCTR20210526003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210526003.